Sep 2026· La Clinica pediatrica· pp.
99228261480530
· 0 citations· 68 references
Medicine
TL;DR
Significant heterogeneity in strains, dosing, and study design limits generalizability of probiotic efficacy in pediatrics, and standardized RCTs and precision microbiome approaches are required.
Abstract
Background
The pediatric gut microbiome influences immune maturation, neurodevelopment, and disease susceptibility. Probiotic supplementation has been investigated across multiple childhood conditions, yet strain-specific efficacy remains inconsistent.
Objective
The objective of this review is to systematically evaluate strain-specific probiotic interventions in children and assess clinical efficacy, safety, and mechanistic pathways.
METHODOLOGY
A systematic review was conducted following PRISMA 2020 guidelines. PubMed, Scopus, and Web of Science were searched for studies (2006-2024).
Results
Strong evidence supports Lactobacillus rhamnosus GG and Saccharomyces boulardii for acute diarrhea. Mixed strains show moderate benefit in atopic dermatitis. Adjunct probiotic therapy improves Helicobacter pylori eradication rates. Evidence in asthma and autism spectrum disorder remains preliminary.
Conclusion
Significant heterogeneity in strains, dosing, and study design limits generalizability. Probiotic efficacy in pediatrics is strain and condition-specific. Standardized RCTs and precision microbiome approaches are required.
Probiotic supplementation has gained increasing attention as a strategy to improve gut health by modulating the intestinal microbiota, strengthening the gut barrier, and regulating immune responses. However, probiotic efficacy is strain-specific, and evidence comparing the benefits of different probiotic species remain...
Khairunnisa Berawi, Sutopo Hadi, M. E. Kustyawati et al.· Jurnal Kesehatan· 0 citations
It is concluded that multi-strain probiotics reduce severe NEC and all-cause mortality, but evidence for LOS is inconsistent and neurodevelopmental benefit remains unproven, and routine universal use is not justified.
Small intestinal bacterial overgrowth (SIBO) is a heterogeneous disorder in which excessive or altered microbial populations in the small intestine coexist with disturbances in motility, anatomy, host defenses, and luminal ecology. Although antibiotics remain the best-studied pharmacological treatment, incomplete respo...
J. D. de Carvalho· International Journal of Pha...· 0 citations
Metabolic syndrome (MetS), characterized by obesity, insulin resistance, dyslipidemia, and hypertension, is closely associated with gut microbiota dysbiosis. Increasing evidence suggests that probiotics may restore microbial balance and alleviate metabolic disturbances. This study reviews the mechanistic roles of probi...
Background/Objectives: Pediatric atopic dermatitis (AD) is a barrier-driven inflammatory skin disease with systemic immune and microbial correlates. The gut–skin axis offers a biologically plausible framework through which early-life nutrition, gut microbial metabolism, intestinal barrier function, and immune maturatio...
Raluca Miulescu, Mihnea Costescu, R. Marin et al.· Nutrients· 0 citations
The intestinal microbiota is a central regulator of mucosal and systemic immunity, and its disruption is strongly associated with chronic inflammatory disease. Probiotics defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host are increasingly used to modulate gut...
Mihai Folescu, Maria-Larisa Ardelean (căs.Rusu), F. Muselin et al.· Romanian Journal of Veterina...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.